Tesamorelin / Ipamorelin (13/3 MG)Lot I/T002 · Reported August 21, 2026
Original Certificate of Analysis, accession 2608141127, for Tesamorelin / Ipamorelin (13/3 MG) · Lot I/T002. Full reported values are available in the text below and original PDF.
Report details as text
Product on certificate
Tesamorelin/Ipamorelin 13mg/3mg
Lot
I/T002
Accession
2608141127
Search code
Regu2608141127
Laboratory
Freedom Diagnostics
Received
August 14, 2026
Reported
August 21, 2026
Identity (LC-MS)
Ipamorelin/Tesamorelin
Purity (HPLC-UV)
99.32%
Net content
Ipamorelin – 3.46 mg; Tesamorelin – 14.50 mg
Appearance
White Lyophilized Powder
Method
HPLC with UV detection coupled with mass spectrometry (LC-MS).
Report context
Purity is reported for the blend, not separately for each ingredient.

This transcription accompanies the original certificate. Refer to the PDF for all figures and statements. Research use only; not for human or animal use.